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Background: To report the findings of preoperative screening regarding prevalence of Hepatitis B and Hepatitis C
in patients presenting for cataract surgery.
Findings: A descriptive study was conducted among 377 patients presenting for cataract surgery to Department of
Ophthalmology Unit I, CHK from April 2010 to May 2011. Convenience sampling was done to recruit the
participants aged 18 years and above. The patients were screened for Hepatitis B and C infections and findings
were recorded on a structured compilation sheet.
The total prevalence of both Hepatitis B and Hepatitis C in preoperative Cataract patients was found to be 49 out
of 377(12.99%). Overall, 8 out of 377 (2.1%) patients were HBsAg positive and 42 out of 377 (11.1%) were Anti-HCV
positive. Only 1 patient was found with a co-infection with both HBsAg and Anti-HCV positive.
Conclusions: High proportions of Hepatitis B and C are reported among preoperative cataract patients of Karachi.
Routine serological screening prior to surgery should be made mandatory so that asymptomatic patients would no
longer pose a threat to its spread.
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Hepatitis is described as an infection with swelling and
inflammation of the liver that if progresses, may lead to
cirrhosis or cancer [1]. Sometimes people contract hepa-
titis with limited or no symptoms but often it leads to
jaundice, anorexia (poor appetite) and diarrhea. Hepatitis
is caused by a wide variety of causatives like alcohol, poi-
son and autoimmunity but most cases of hepatitis are
reported by viruses [1].
Hepatitis B (HBV) and Hepatitis C (HCV) are one of
the viral types of Hepatitis that lead to irritation,
inflammation and swelling of the liver capable of causing
acute and chronic form of hepatitis [2]. Worldwide 2 bil-
lion people have been infected with HBV and 350 mil-
lion (5-15% of the total cases) are carriers of the virus
[3]. According to WHO estimates, HCV prevalence is
3% of world population with 170 million cases. Almost* Correspondence: abdulnafey@hotmail.com
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reproduction in any medium, provided the or50% of all cases become chronic carriers at risk of liver
cirrhosis and liver cancer [4].
HBV can be contracted through the blood, semen, va-
ginal fluids, and other body fluids of an infected individ-
ual having hepatitis B infection [2]. HCV however, can
only be contracted through blood to blood contact [5].
The transmission risk of these diseases is more among
patients receiving blood transfusions or injection drug
users [6].
Unfortunately, once inflicted, these infections show
poor response to the available treatment modalities.
Therefore precautionary methods are considered the
best way to avoid spreading of this disease. Unlike HCV,
several vaccines have been developed for HBV that pro-
vide long lasting immunity to individuals [7]. It is the
most important precautionary measure of HBV as a vac-
cinated individual may never contract the infection [8].
Both infections, especially the risk of HCV, can be fur-
ther avoided by use of disposable syringes, screened
blood transfusion, avoidance of sexual abuse, antiseptic
shaving and use of proper antiseptic measures in hospi-
tals, clinics and operation theaters [6].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Although Pakistan is in a moderate Hepatitis B preva-
lence area, chronic hepatitis B is still a severe problem
with a carrier rate of 3-4% [9,10]. Hepatitis B infected
blood or fluids is considered the major source of trans-
mission of the disease in Pakistan [11]. On the other
hand, Pakistan is considered among the high risk areas
of Hepatitis C with about 10 million Pakistani popula-
tion is infected with Hepatitis C [12] at a prevalence rate
of 4-10% [13]. Blood transfusions is still the major cause
of HCV transmission in Pakistan; as a survey of blood
banks in the large urban centers of the country showed
that only about 25% of them tested blood and blood
product donations for HCV to keep the cost down [14].
The prevalence of HBsAg and anti-HCV in hospita-
lized surgical patients is very high. There is lack of rou-
tine serological screening prior to surgery which is one
of the factors responsible for increased disease transmis-
sion. The major risk factors include re-use of contami-
nated syringes, surgical instruments and improperly
screened blood products [6].
Cataracts are changes in clarity of the natural lens in-
side the eye that gradually degrade visual quality [15].
Cataracts develop for a variety of reasons, including
long-term exposure to ultraviolet light, exposure to radi-
ation, secondary effects of diseases such as diabetes, and
many more. According to a survey conducted in 2007,
an estimated 570 000 individuals are bilaterally blind
from cataract in Pakistan which is a very significantly
high number [16]. There is no non surgical treatment
for cataract except some preventive measures. Cataract
surgery is the only way of treating this disease. Oper-
ation to remove cataracts can be performed at any stage
of their development. Nowadays cataract operation can
be performed anytime depending upon the visual
requirements of the patient [17]. However, because all
surgery involves some risk, it is usually worth waiting
until there is some change in vision before removing the
cataract [17].
The aim of our current study was to estimate the
prevalence of Hepatitis B and Hepatitis C among pre-
operative cataract patients of Karachi, Pakistan. We
hypothesized that the prevalence of Hepatitis B and
Hepatitis C would be higher than 5% among preopera-
tive cataract patients.
Methods
The study was approved by Ethical review Committee of
Dow University of Health Sciences. All subjects’ infor-
mation was kept confidential and written informed con-
sent was obtained.
It was a descriptive study based on a survey in Depart-
ment of Ophthalmology, Unit I Civil Hospital Karachi.
All patients admitted for cataract operation from 1stApril 2010-1st May 2011 were screened for Hepatitis B
and Hepatitis C infections. Out of the intended sample
size of 400 screened cataract patients, 377 patients
agreed to participate in the study while 23 patients
refused consent later on for various reasons like patient
denial. Thus the original sample size of 400 patients
could not be completed.
Data was collected on the patients’ clinical history and
co-morbidities. The findings were recorded in a struc-
tured compilation sheet and analyzed through applica-
tion of statistical tools of analysis. A descriptive
statistical analysis was carried out on SPSS 17 software.
All patients of 18 years and above that presented
themselves with cataract at the Department of Ophthal-
mology were included in the study. Patients below
18 years or having any other eye operation besides cata-
ract like glaucoma were excluded from the study.
Rapid chromatography immunoassay for qualitative
detection of surface antigen of hepatitis B and antibodies
for hepatitis C was the screening technique used in the
study. Results that were found positive on screening test
were confirmed by ELISA (Enzyme-Linked Immuno-
sorbent Assay) method on (Evolus –4th generation
ELISA).Findings
A total of 377 out of the intended sample of 400 patients
were included in the study. 23 participants refused
consent.
Subjects comprised of 200(53.1%) males and 177
(46.9%) females with a mean age of 54.16. The total
prevalence of both Hepatitis B and Hepatitis C in pre-
operative Cataract patients was found to be 12.99% (49/
377) with Hepatitis C having a higher prevalence of
11.1% (42/377) in comparison to Hepatitis B prevalence
of 2.1% (8/377).
14.5% (29/200) of the total male population and 11.3%
(20/177) of the total female population were positive for
Hepatitis B and Hepatitis C infections.
Male predominance in the total number of positive
cases was 59.18% (29/49) in comparison to females with
40.82% (20/49). Only one female patient was found to
have co-infection of both Hepatitis B and Hepatitis C.
Individually, Hepatitis B was more common in males
75% (6/8) than females 25% (2/8). Similarly Hepatitis C
was also common in males with 54.75% (23/42) in com-
parison to females 45.25% (19/42) (Table 1).Discussion
Hepatitis B and Hepatitis C are global diseases that are
endemic in many countries. Hepatitis C, in combination
with hepatitis B, accounts for 75% of all cases of liver
disease around the world [18]. Many Asian countries are
Table 1 Representating data of our study
MALE FEMALE TOTAL
NO. OF SUBJECTS 200 177 377
POSITIVE HEPATITIS B CASES 6 2* 8
POSITIVE HEPATITIS C CASES 23 19* 42
PREVALENCE OF POSITIVE CASES
PER POPULATION
14.5% 11.3% 12.99%
*One female had a co-infection of both Hepatitis B and Hepatitis C.
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[3,19].
Pakistan, like many developing countries, has a high
incidence of Hepatitis B and Hepatitis C of 10% and 4-
7% respectively [20]. The prevalence is continuing to rise
[21] and in certain parts, especially in the rural areas,
the percentage of infected individuals is significantly
higher than those reported [22,23].
The total prevalence of Hepatitis B and Hepatitis C in
this study was found to be 12.99%. This was higher in
comparison to Iftikhar et al found to be 5.75% [24].
However, Khan et al, showed a double prevalence of 24%
on eye camps in rural Sindh, rather than hospitalized
patients [20]. Ali et al reported HBV prevalence of 3.89%
±1.004% in Pakistani ophthalmic patients [25]. The
higher prevalence in eye camps in comparison to hospi-
talized patients may be due to the fact that the study
was conducted in rural areas and had a longer duration
of time. Our study comprised of a mixed population of
urban population of Karachi, periphery of Karachi and
rural areas of Sindh and Baluchistan.
Hepatitis B and Hepatitis C prevalence in preoperative
cataract patients was found to be higher in males
(59.18%) than females (40.82%). Iftikhar et al also
showed that the total prevalence of Hepatitis B and
Hepatitis C in males was very high compared to females
among preoperative cataract patients of DI Khan [24]. In
other different studies done in the country, similar find-
ings and results were seen where males predominated
females [26-29]. The reason may be attributed to the fact
that males in Pakistan have a higher social mobility and
freedom, especially in rural areas as compared to
females. Thus they have a greater chance of contracting
the infection.
Some studies however contradicted the result, with
females having a higher prevalence than males [30,31].
A study conducted in 2010 on different eye camps in
Pakistan showed that 108 out of 437 patients were
infected with Hepatitis B and Hepatitis C with a higher
prevalence of the diseases in females with 60.18% (65/
108) than in males with 39.81% (43/108) [20].
The highest number of positive cases of Hepatitis B
and Hepatitis C in our study, were found in age group50-85. As far as cataract patients are concerned, Iftikhar
et al also had similar results where both hepatitis B and
C were seen to be highly prevalent in the age group be-
tween 55-64 years [24].
A study done only on Hepatitis C prevalence in eye
camps in Pakistan in 2008, showed that incidence
increased as the age increased in study patients. Hepa-
titis C prevalence was 42.3% in less than 60 years of age
to 57.7% in more than 60 years of age [32]. High inci-
dence of Hepatitis C was also seen in a similar study in
Japan [33]. Age group 18-30 had the least positive cases
comparable to the D.I Khan study where prevalence of
HBV and HCV infections was also least in the age group
25-34 years [24].
Age-related cataract is responsible for 48% of world
blindness, which represents about 18 million people,
according to the World Health Organization (WHO)
[33]. Pakistan also has a higher incidence of cataract
patients [16]. The higher prevalence of Hepatitis B and
Hepatitis C in older age groups can be due to the fact
that the incidence of age related cataract is very com-
mon. A Japanese study supported this by concluding
that Hepatitis C may play a part in older people for
developing cataracts [34].
There were however a number of limitations to our
study. Hepatitis B and Hepatitis C prevalence in children
of Pakistan has seen a major rise in the past few years
[35]. However our study was not conducted on partici-
pants below 18 years. Because this study was conducted
among patients of certain age (and certain age related
disease = cataract) the prevalence we found could be
over or underestimated. Another limitation of this study
is because of the study design other risk factors such as
medical care related factors (previous surgeries) drug
use, risky sexual behavior, tattooing etc which can influ-
ence the presence of hepatitis infection were not
obtained. Thus we could only speculate about the age
and gender differences in the prevalence. Further studies
are needed to address these issues.
With such a higher prevalence of the viral diseases in
the population, it is important that patients be regularly
screened for Hepatitis B and Hepatitis C. Media should
be used as a tool to spread awareness in the public.
Conclusion
No study is available on hepatitis B and C infection
among preoperative cataract patients in Karachi. The
aim of the present study was to assess the prevalence of
HBV and HCV infection among preoperative cataract
patients in Karachi. Routinely screening of preoperative
cataract patients are still not carried out. Awareness
among doctors to carry out such screening of preopera-
tive patients is necessary for patients’ safety. We hope
that this study will prove a stepping stone to implement
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Competing interests
The authors declare that they have no competing interests.
Author’s contributions
SSN: wrote article and decided topic. EUS: wrote article and decided the
topic. ANK: Did data collection and wrote paper. STK: Did data collection. FE:
Help review manuscript and make changes. IA: Help review manuscript and
make changes. All authors read and approved the final manuscript.
Author details
1Chairman Department of Ophthalmology, Dow University of Health
Sciences, Karachi, Pakistan. 2Medical Students, Dow Medical College, DUHS,
109/2, Popular Avenue, Phase 6, D.H.A, Karachi, Pakistan. 3Associate Professor
Microbiology Dow Medical College, Karachi, Pakistan.
Received: 29 March 2012 Accepted: 31 August 2012
Published: 6 September 2012
References
1. Hepatitis: http://www.nlm.nih.gov/medlineplus/hepatitis.html.
2. Hepatitis B: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001324/.
3. World Health Organization: Hepatitis B. (Fact sheet no. 204). Geneva,
Switzerland: World Health Organization; 2000.
4. World Health Organization: Hepatitis C. (Fact sheet no. 204). Geneva,
Switzerland: World Health Organization; 2000.
5. Maheshwari A, Thuluvath PJ: Management of acute hepatitis C. Clinics in
liver disease 2010, 14(1):169–176.
6. The ABC’s of Hepatitis: http://www.hepfi.org/living/liv_abc.html.
7. Vandamme P, Van Herck K: A review of the long-term protection after
hepatitis A and B vaccination. Travel Medicine and Infectious Disease 2007,
5(2):79–84.
8. Kevorkyan AK, Teoharov PB, Petrova NS, Baltadzhiev IG, Stoilova YD,
Angelova NG, Plachkova AD: Immune response and immunologic
memory in medical personnel vaccinated with hepatitis B vaccine. Folia
Med 2011, 53(3):32–38.
9. Andre F: Hepatitis B, epidemiology in Asia: the Middle East and Africa.
Vaccine 2000, 18(1):20–22.
10. Khan AA, Rehman KU, Haider Z, Shafqat F: Sero-markers of hepatitis B and
C in patients with cirrhosis. J Coll Phys Surg Pak 2002, 12:105–107.
11. Abdul-Mujeeb S, Jamal Q, Khanani R, Iqbal N, Kaher S: Prevalence of
hepatitis B surface antigen and HCV antibodies in hepatocellular
carcinoma cases in Karachi, Pakistan. Trop Doct 1997, 27:45–46.
12. Umar M, Bilal M: Hepatitis C, A Mega Menace: A Pakistani Perspective.
J Pak Med Stud 2012, 2(2):68–72.
13. World Health Organization: WHO Hepatitis C factsheet.; 2011. http://www.
who.int/mediacentre/factsheets/fs164/en/index.html.
14. Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, Mirza S, Malik T,
Fisher-Hoch S, McCormick JB: Unsafe injections and the transmission
hepatitis B and C in a periurban community in Pakistan. Bull World Health
Organ 2000, 78:956–963.
15. Cataracts: http://www.emedicinehealth.com/cataracts/article_em.htm.
16. Jadoon Z, Shah SP, Bourne R, Dineen B, Khan MA, Gilbert CE, Foster A, Khan
MD: Cataract prevalence, cataract surgical coverage and barriers to
uptake of cataract surgical services in Pakistan: the Pakistan National




18. Hepatitis C an endemic: http://www.epidemic.org/thefacts/theEpidemic/
worldPrevalence/.
19. Hepatitis C: http://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-
infectious-diseases-related-to-travel/hepatitis-c.htm.
20. Nangrejo KM, Qureshi MA, Sahto AA, Siddiqui SJ: Prevalence of Hepatitis B
and C in the patients Undergoing Cataract Surgery at Eye Camps. Pak J
Ophthalmol 2011, 27:1.
21. Khokhar N, Gill ML, Malik GL: General seroprevance of hepatitis B and C
infection in the population. J Coll Phy Surg Pak 2004, 14:534.22. Malik IA, Kaleem SA, Tarique WUZ: Hepatitis C infection inprospective,
where do we stand? J Coll Phy Surg Pak 1999, 9:234–237.
23. Yousaf A, Mohammad A, Ishaque M, et al: Can we afford to operate on
patients without HBs Ag screening? J Coll Phys Surg Pak 1996, 9:98–100.
24. Ahmad I, Khan SB, Rehman HU, Khan MH, Anwar S: Frequency of Hepatitis
B and Hepatitis C among cataract patients. Gomal Journal of Medical
Sciences 2006, 4:2.
25. Ali M, Idrees M, Ali L, Hussain A, Rehman I, Saleem S, Afzal S, Butt S:
Hepatitis B virus in Pakistan: A systematic review of prevalence, risk
factors, awareness status and genotypes. Virol J 2011, 8:102.
26. Khan TS, Rizvi F: Hepatitis B seropositivity among Chronic Liver Disease
patients in Hazara Division Pakistan. J Ayub Med Coll Abottabad Sept 2003,
15:54–55.
27. Mashud I, Khan H, Khattak AM: Relative Frequency of Hepatitis B and Hepatitis
C viruses in patients with Hepatic Cirrhosis at DHQ Teaching Hospital DI Khan
Mar J Ayub Med Coll Abbottabad 2004, 16:32–34.
28. Khan AJ, Siddiqui TR: Prevalence of Hepatitis B and C screening in cases
undergoing Elective eye surgery. Pak J Opthalmol 2007, 23:39–44.
29. Farooqi JI, Farooqi RJ: Relative Frequency of Hepatitis B and Hepatitis C
virus infections in cases of hepatocelluar Carcinoma in NWFP, Pakistan.
J Coll Phys Surg Pak 2000, 10:128–130.
30. Farooqi JI, Farooqi RJ: Relative Frequency of Hepatitis B and Hepatitis C
virus infections in patients of cirrhosis in NWFP, Pakistan. J Coll Phys Surg
Pak 2000, 10:217–219.
31. Chauadry IA, Khan SA, Samiullah: Should we do Hepatitis B and Heaptitis
C screening on each patient before surgery: analysis of 142 cases. Pak J
Med Sci 2005, 21(3):278–280.
32. Mahmood T, Iqbal M: Prevalence of Anti Hepatitis C Virus (HCV)
Antibodies in Cataract Surgery Patients. Pak J Ophthalmol 2008, 24:1.
33. World Health Organization: WHO.int, Priority eye diseases http://www.who.
int/blindness/causes/priority/en/.
34. Yoshida K, Nakan H, Yoshitomi F, Oshika T: Prevalence of seropositivity for
hepatitis C virus in cataract patients and the general population.
J Cataract Refract Surg 2002, 28:1789–1792.
35. hepatitis-b-c-rise-among-children-blamed-on-extensive-use-of-injections:
Dawn News.; 2011. July 27.
doi:10.1186/1756-0500-5-492
Cite this article as: Naeem et al.: Prevalence of Hepatitis ‘B’ and
Hepatitis ‘C’ among preoperative cataract patients in Karachi. BMC
Research Notes 2012 5:492.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
